Cent, the preventive-health startup founded by Practo co-founder Shashank ND, closed a $15 million Series A this week led by Blume Ventures and existing backer South Park Commons, with individual investors including former Vodafone CEO Arun Sarin joining in. The company runs centres offering full-body scans aimed at catching disease early, and says its long-term goal is 10 million scans by 2035. Alongside the raise, Cent announced it is acquiring Medsee, an AI radiology startup, a detail that got a fraction of the coverage the funding number did and is arguably the more interesting decision.
Why the acquisition matters more than the amount
A $15 million Series A is a respectable but unremarkable number in Indian healthtech. Folding in an acquisition on the same day the round is announced is not routine, and it tells a reader something the number alone doesn’t: Cent isn’t treating this round as fuel for marketing spend or clinic count. It’s treating it as a chance to buy a capability - AI-assisted radiology reads - that would otherwise take years to build in-house, inside an announcement that was always going to get covered anyway.
The trust problem a full-body scan business can’t market its way around
A full-body scan is a hard sell on advertising alone, because the thing being bought is reassurance about a result the customer can’t verify themselves. Shashank ND’s prior company, Practo, spent a decade building exactly that kind of trust with doctors and patients before this founder started a company that depends on it even more directly. That history is doing work no ad campaign could do as fast - it’s the reason a new entrant in preventive diagnostics gets taken seriously in week one instead of having to earn it from zero.
What the Medsee deal actually signals to a patient
Folding in a radiology AI startup, rather than just hiring radiologists or outsourcing reads, is a bet that the accuracy claim behind a full-body scan has to be defensible at the infrastructure level, not just the marketing level. For a category where a single misread result can end a company’s credibility in one news cycle, owning the read pipeline instead of renting it is the quieter, more expensive way to make the trust claim real.